|Datasheet||Specific References||Reviews||Related Products||Protocols|
|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive, Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
A myc tag can be used in many different assays that require recognition by an antibody. If there is no antibody against the studied protein, adding a myc-tag allows one to follow the protein with an antibody against the Myc epitope. Examples are cellular localization studies by immunofluorescence or detection by Western blotting.
The peptide sequence of the myc-tag is: N-EQKLISEEDL-C (1202 Da). It can be fused to the C-terminus and the N-terminus of a protein. It is advisable not to fuse the tag directly behind the signal peptide of a secretory protein, since it can interfere with translocation into the secretory pathway.
|Human HB-EGF ORF mammalian expression plasmid, C-GFPSpark tag||HG10325-ACG|
|Human HB-EGF ORF mammalian expression plasmid, C-OFPSpark / RFP tag||HG10325-ACR|
|Human HB-EGF ORF mammalian expression plasmid, C-Flag tag||HG10325-CF|
|Human HB-EGF ORF mammalian expression plasmid, C-His tag||HG10325-CH|
|Human HB-EGF ORF mammalian expression plasmid, C-Myc tag||HG10325-CM|
|Human HB-EGF ORF mammalian expression plasmid, C-HA tag||HG10325-CY|
|Human HB-EGF Gene cDNA clone plasmid||HG10325-M|
|Human HB-EGF ORF mammalian expression plasmid, N-Flag tag||HG10325-NF|
|Human HB-EGF ORF mammalian expression plasmid, N-His tag||HG10325-NH|
|Human HB-EGF ORF mammalian expression plasmid, N-Myc tag||HG10325-NM|
|Human HB-EGF ORF mammalian expression plasmid, N-HA tag||HG10325-NY|
|Human HB-EGF natural ORF mammalian expression plasmid||HG10325-UT|
|Learn more about expression Vectors|
Heparin-binding EGF-like growth factor (HBEGF), a member of the EGF family of growth factors, exerts its biological activity through activation of the EGFR and other ErbB receptors. Soluble mature HBEGF is proteolytically processed from a larger membrane-anchored precursor and is a potent mitogen and chemotactic factor for fibroblasts, smooth muscle cells but not endothelial cells. HBEGF activates two EGF receptor subtypes, HER1 and HER4 and binds to cell surface HSPG. The transmembrane form of HBEGF is a juxtacrine growth and adhesion factor and is uniquely the receptor for diphtheria toxin. Both forms of HB-EGF participate in normal physiological processes and in pathological processes including tumor progression and metastasis, organ hyperplasia, and atherosclerotic disease. HBEGF participates in diverse biological processes, including heart development and maintenance, skin wound healing, eyelid formation, blastocyst implantation, progression of atherosclerosis and tumor formation, through the activation of signaling molecules downstream of ErbB receptors and interactions with molecules associated with HBEGF. tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta markedly increased HB-EGF mRNA levels in HUVEC by 12- and 7-fold, respectively, and induction of the gene by TNF-alpha was both dose- and time-dependent.